Content area

Abstract

Background

Sepsis is a life-threatening condition caused by an excessive inflammatory response to an infection, associated with high mortality. However, the regulatory mechanism of sepsis remains unclear.

Results

In this study, bioinformatics analysis revealed the novel key biomarkers associated with sepsis and potential regulators. Three public datasets (GSE28750, GSE57065 and GSE95233) were employed to recognize the differentially expressed genes (DEGs). Taking the intersection of DEGs from these three datasets, GO and KEGG pathway enrichment analysis revealed 537 shared DEGs and their biological functions and pathways. These genes were mainly enriched in T cell activation, differentiation, lymphocyte differentiation, mononuclear cell differentiation, and regulation of T cell activation based on GO analysis. Further, pathway enrichment analysis revealed that these DEGs were significantly enriched in Th1, Th2 and Th17 cell differentiation. Additionally, five hub immune-related genes (CD3E, HLA-DRA, IL2RB, ITK and LAT) were identified from the protein–protein interaction network, and sepsis patients with higher expression of hub genes had a better prognosis. Besides, 14 drugs targeting these five hub related genes were revealed on the basis of the DrugBank database, which proved advantageous for treating immune-related diseases.

Conclusions

These results strengthen the new understanding of sepsis development and provide a fresh perspective into discriminating the candidate biomarkers for predicting sepsis as well as identifying new drugs for treating sepsis.

Details

1009240
Business indexing term
Company / organization
Title
Exploring the biomarkers and potential therapeutic drugs for sepsis via integrated bioinformatic analysis
Publication title
Volume
24
Pages
1-14
Publication year
2024
Publication date
2024
Section
Research
Publisher
Springer Nature B.V.
Place of publication
London
Country of publication
Netherlands
e-ISSN
14712334
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2024-01-02
Milestone dates
2023-06-01 (Received); 2023-12-08 (Accepted); 2024-01-02 (Published)
Publication history
 
 
   First posting date
02 Jan 2024
ProQuest document ID
2914276879
Document URL
https://www.proquest.com/scholarly-journals/exploring-biomarkers-potential-therapeutic-drugs/docview/2914276879/se-2?accountid=208611
Copyright
© 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2024-10-03
Database
ProQuest One Academic